Hypaque Injection and Ranibizumab
Determining the interaction of Hypaque Injection and Ranibizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: diatrizoate
Brand name: Cystografin, Cystografin-Dilute, Gastrografin, MD-76 R, MD-Gastroview
Synonyms: Diatrizoate Meglumine
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hypaque Injection-Ranibizumab Intraocular
- Hypaque Injection-Ranibizumab ophthalmic
- Hypaque Injection-Ranitidine
- Hypaque Injection-Ranitidine Capsule
- Hypaque Injection-Ranitidine Hydrochloride
- Hypaque Injection-Ranitidine Injection
- Ranibizumab-Hypaque Meglumine
- Ranibizumab-Hypaque-76
- Ranibizumab-Hypaque-Cysto
- Ranibizumab-Hyper-Sal inhalation
- Ranibizumab-Hyperhep B
- Ranibizumab-HyperHEP B S/D